ライフサイエンスコーパス: death rate

1 below both ECG thresholds (13.9% versus 5.5% death rate).

2 ature corresponded to an increase of 2.5% in death rate.

3 progeny with low viability and high cellular death rate.

4 nosis, with a very high in-hospital and late death rate.

5 a were independently associated to increased death rate.

6 ey data for occupation and industry-specific death rates.

7 rall CVD rates and racial disparities in CVD death rates.

8 a significant impact on human cause-specific death rates.

9 city is also related to human cause-specific death rates.

10 individual protective measures increase with death rates.

11 gression of lung injury and reduce influenza death rates.

12 n severe human respiratory disease with high death rates.

13 e annual percentage changes in incidence and death rates.

14 , in particular by differences in progenitor death rates.

15 55 years), CGS was lowered by higher patient death rates.

16 ng cessation at any age dramatically reduced death rates.

17 ty-level, age-adjusted liver disease-related death rates.

18 with agency characteristics and state opioid death rates.

19 iven the enormity of earlier declines in CVD death rates.

20 Pan also exhibited elevated gene death rates.

21 ial inter-patient variation of cell survival/death rates.

22 tissue and determines cell proliferation or death rates.

23 tes, but switches to proliferation at higher death rates.

24 subnational age-specific and period-specific death rates.

25 rates for each country in addition to crude death rates.

26 g projections of population obesity and ESRD death rates.

27 have comprehensive information on birth and death rates.

28 critical congenital heart disease and infant death rates.

29 ted with hospital-level 30-day postoperative death rates.

30 of its cells exceeds their total mortality (death) rate.

31 major adverse cardiac event rate was 19.9% (death rate: 1.2%; recurrent MI: 16.8%; stroke/transient

32 Exposed infants had a lower hospital death rate (14.2% vs 18.5% ; OR, 0.73 [95% CI, 0.54 to 0

33 by a significantly higher induction-related death rate (2.5% vs 0.9%, P = .00013), resulting in 5-ye

34 ate compared to the province with the lowest death rate, 2.2 times higher in black Africans compared

35 52%; P = .14) as a result of a higher early death rate (26% vs 14%; P = .06).

36 Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was observed

37 The remarkable reduction in death rates achieved with these therapies has resulted i

38 Combined BPD or death rates across 116 NICUs varied from 17.7% to 73.4%

39 e observed striking differences in birth and death rates across miRNA classes defined by biogenesis p

40 There was evidence of heterogeneity of death rates across studies (chi(2) = 22.6; df = 8; P = 0

41 ur health outcomes were investigated: annual death rate, Activities of Daily Living (ADL), physical p

42 The crude annual death rate after a spontaneous bleed (9.5%) or MI (7.6%)

43 s in the hospital-level 30-day postoperative death rate after inpatient surgery ranging from 14% to 2

44 The cell death rate after MNFH was dramatically decreased by incr

45 ined the model parameters (such as birth and death rates, age-specific incidence rates, and age-speci

46 ly worse than the EU15+ for age-standardised death rates, age-standardised YLL rates, and life expect

47 rborne viruses that lead to high disease and death rates all over the world.

48 The male radiologists had lower death rates (all causes) compared with the psychiatrists

49 sector, because lung cancer has the highest death rate among all cancer types, and it brings a high

50 The mean liver-related death rate among the general population during the study

51 We examined 30-year cause-specific death rates among 21 693 MI patients <50 years versus 21

52 from 13 sub-Saharan African studies tracking death rates among adult patients who were lost to follow

53 owed a rapid increase in prescription opioid death rates among the white male population aged 30-39 b

54 ause mortality, as well as AIDS and non-AIDS death rates, among patients started on antiretroviral th

55 TD increases the death rate and can be minimized by limiting use of typic

56 ing co-morbidities, including cardiovascular death rate and smoking prevalence, were significantly as

57 ic nanofluid hyperthermia (MNFH) on the cell death rate and the heat shock proteins 72 (HSP72) induct

58 It was clearly observed that the cell death rate and the HSP72 induction rate had a strong dep

59 eteriorating environments, one with a rising death rate and the other one with decreasing nutrient av

60 ed economic insecurity in increasing midlife death rates and "deaths of despair," including suicide,

61 , we calculated age-adjusted, HCV-associated death rates and compared death rate ratios (DRRs) for 10

62 the smallest error to forecast age-specific death rates and life expectancy to 2030 for 375 of Engla

63 We compared overall and cause-specific death rates and mean ages at death between CHeCS CHB dec

64 County-level death rates and national life tables for each year were

65 nd annual percent change in age-standardized death rates and years of potential life lost before age

66 would be seen in the 2030 population at 2010 death rates), and improve health care at all ages".

67 ects on intensive care unit (ICU) demand and death rate, and compared with Swedish data for April 202

68 genesis (the cell-cycle rate, the progenitor death rate, and the "quit rate," i.e., the ratio of term

69 -49 years that would be seen in 2030 at 2010 death rates, and about 17 million of the 41 million such

70 ery to decreased ceramide levels, lower cell death rates, and changes in the composition of the immun

71 dimycocerosate (PDIM) exhibited significant death rates, and consequently, total bacterial numbers w

72 s among smokers are avoidable at non-smoking death rates, and former smokers have about only a quarte

73 tation, metastasis, intrinsic cell birth and death rates, and the details of cell competition.

74 diet, risk characteristics, disease-specific death rates, and their ecologic and individual associati

75 While death rates are encouraging, efforts to reduce loss to f

76 e-adjusted HF-related cardiovascular disease death rates are higher for Black patients, particularly

77 Cardiovascular disease (CVD) death rates are much higher in blacks than whites in the

78 ly lower hospital-level 30-day postoperative death rates (aRR 0.83, 95% CI 0.70-0.97, P = 0.02).

79 and cerebrovascular disease age-standardized death rates (as per International Classification of Dise

80 tandardized incidence rate, age-standardized death rate (ASDR), and age-standardized DALY rate increa

81 1,659 cancer deaths in men (age-standardized death rate, ASDR, 158.5/100,000) and 78,918 in women (AS

82 ially in women, seems to modify the elevated death rate associated with high milk consumption.

83 estinal events; there was no increase in the death rate at days 60 + 90.

84 Severe bronchopulmonary dysplasia/death rates at 36 weeks' postmenstrual age were similar

85 tancy at birth and HALE increased, all-cause death rates at all ages decreased, and age-specific rate

86 ality model revealed substantive declines of death rates at every age in most countries but with nota

87 Age-standardized CVD death rates attributable to established risk factors plu

88 no difference in noncardiovascular or cancer death rates between groups.

89 ith hepatitis C virus infection and compared death rates between waiting list and kidney transplantat

90 y time during MNFH affects not only the cell death rate but also HSP72 induction rate.

91 treatment can change cancer incidence and/or death rates, but it will require a concerted effort by t

92 A concave tradeoff favors migration at low death rates, but switches to proliferation at higher dea

93 Second, we smoothed raw estimates of death rates by age and time by using a two-dimensional P

94 oson (LTR-RT) type of TE, we estimated their death rates by counting solo-LTRs and truncated elements

95 f the effect of smoking on mortality yielded death rates by smoking status.

96 In particular, changes in proliferation and death rates can be mistaken for cell flux.

97 We incorporated a cell death rate (CDR) function into a previous dynamical PSA

98 epair in ESRD patients had complications and death rates comparable with non-ESRD patients.

99 imes higher in the province with the highest death rate compared to the province with the lowest deat

100 Il6-deficient mice had a lower death rate compared with wild-type mice with AP, while m

101 The co-cases showed increased death rates compared with the co-controls (hazard ratio,

102 y, we calculated age-adjusted HCV-associated death rates, compared death rate ratios (DRR) for ten US

103 Congenital heart defect (CHD)-related death rates correlated with defect severity.

104 Some very low death rate countries such as Eastern Asia, Central Europ

105 due to the restrictive choices of birth and death rate curves through time.

106 Trauma deaths and death rates deceased in individuals younger than 25 year

107 th rate, with a probability of 0.97 that the death rate declined at 6 y after implementation.

108 Although overall MVA death rates declined during this period, socioeconomic d

109 Although overall age-standardised death rates decreased by 29.0% (28.7 to 29.3) from 1990

110 Birth and death rates determine the pace of population increase or

111 The at-home death rate due to respiratory syncytial virus infection

112 erica and Ceara State has one of the highest death rates due to histoplasmosis in the world, where th

113 The early death rate during induction therapy was 10.3% in the GO

114 Death rate during the study period was 16/843 (2%), sign

115 Large differences in COVID-19 death rates exist between countries and between regions

116 This ecologic study notes that fetal death rates (FDR) during the Washington DC drinking wate

117 The accident death rate fell sharply among currently deployed soldier

118 Nationally, age-standardised death rates fell 13.3% (11.9-14.6%) since 1990, but stat

119 resource-poor settings, and complication and death rates following surgery are probably substantial b

120 time segment detected by joinpoint analysis, death rate for COPD in men began to decrease and the dec

121 The death rate for COPD increased during this period.

122 olute number of patients and the in-hospital death rate for crucial subcategories such as medical ind

123 verted in each state by applying the average death rate for the five states with the lowest rates amo

124 During this period, death rates for cancer and heart disease decreased.

125 Intracranial bleeds and death rates for dabigatran 150 and 110 mg were lower com

126 Using crude death rates for each country and the calculated proporti

127 Mortality was compared with national death rates for England and Wales, and associations with

128 s and computed age-adjusted and age-specific death rates for the top-named drugs and for prescription

129 Cumulative melanoma-related death rates for thickness groups of patients with thin m

130 s could reduce black-white difference in CVD death rate from 1659 to 1244 per 100 000 in men and from

131 imately 16%-46% of the decreased CVD-related death rate from 1999 to 2014 may be attributable to decr

132 a decrease in the pediatric CHD in-hospital death rate from 5.1 to 2.3 per 100,000 between 1983 and

133 The death rate from HCC was twice that of DCC.

134 tes reduce the recently reported increase in death rate from heart disease.

135 The death rate from hepatocellular carcinoma (HCC) is increa

136 , the incidence of HIV infection exceeds the death rate from HIV, and as a result, the prevalence of

137 The overall death rate from lung cancer is higher in black patients

138 in education-related inequalities in US MVA death rates from 1995 to 2010.

139 GI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and

140 ites was largely accounted for by increasing death rates from drug and alcohol poisonings, suicide, a

141 kers (before 1940) there were also increased death rates from melanoma (RR = 8.75; 95% CI: 1.89, 40.5

142 We use more than six decades of death rates from US hurricanes to show that feminine-nam

143 Vibrio vulnificus has the highest death rate (>35%) and per-case economic burden ($3.3 mil

144 The death rate has decreased, the number of bed days has inc

145 05% versus non-HCC 40.60%), and waiting list death rates (HCC 4.49% versus non-HCC 24.63%).

146 [HR], 0.55; 95% CI, 0.48-0.64), an increased death rate (HR, 1.52; 95% CI, 1.16-2.00), and an overall

147 A high cardiac death rate impacts results of KTA and calls for stringen

148 ected cells showed significant increasing of death rate in hypoxic hepatoma cells compared to control

149 a higher coronavirus disease 2019 (COVID-19) death rate in patients with cancer(2,3), although there

150 Cancer death rate in SOTRs was increased compared with that exp

151 hest adolescent childbirth rate and maternal death rate in sub-Saharan Africa.

152 <4 weeks of aortic constriction, whereas the death rate in the ACi plus CGP group was not different f

153 of EFS, mainly as a result of a higher early death rate in the GO arm.

154 The 30-day death rate in the STEMI cohort was 31.2% and 8.5% in the

155 of Sciences estimated the trauma preventable death rate in the United States to be 20%, issued a call

156 praying through a uniform increase in vector death rates in all sites, and door-to-door application o

157 s being considered by some to reduce cardiac death rates in athletes, but the death rates in defined

158 or emergence rates and an increase in vector death rates in compliant sites only, where control effic

159 uce cardiac death rates in athletes, but the death rates in defined groups screened by the current U.

160 lt mortality by district, notably the higher death rates in eastern India, requires further aetiologi

161 les or cabbage have been associated with low death rates in European countries.

162 and 2013, despite a decrease in age-specific death rates in most regions.

163 CHD death rates in older groups are now falling steeply.

164 Critical congenital heart disease death rates in states with mandatory screening policies

165 veral groups, is associated with higher cell death rates in the left ventricle and deteriorated cardi

166 least education had significantly higher CRC death rates in virtually all states for each racial/ethn

167 , which was probably entirely due to the low death rates in young background population.

168 her results in total birth rate reduction or death rate increase.

169 All-cause age-standardised death rates increased rapidly since 1997, peaked in 2006

170 Mortality assessed by drug overdose death rates involving prescription opioids increased fro

171 However, the death rate is 11.0 deaths per 100 000 person-years becau

172 ing policies has been associated with infant death rates is unknown.

173 mong countries with similar age-standardised death rates, large differences in the onset and patterns

174 Almost all phenotypes we measured, including death rate, metabolite release rate, and the amount of m

175 logical transition models in which decreased death rates occur across all ages.

176 ith neutropenia had a port infection-related death rate of 0.63% (one of 159) versus 0.12% (three of

177 igh with disfiguring treatment options and a death rate of 1 per hour in the United States.

178 c resistance crisis will result in an annual death rate of 10 million people by the year 2050.

179 EF >35%, below-median %PIZ carried an annual death rate of 2.8% versus 12% in patients with above-med

180 elated deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence inter

181 sease study estimate of age-standardized CVD death rate of 272 per 100 000 population in India is hig

182 se mice, consequently leading to a premature death rate of 40% within 2 weeks of treatment, despite d

183 s, leading to kidney failure and a premature death rate of 67% by 9 weeks of age.

184 e of second phase decay is determined by the death rate of infected cells multiplied by the maximum e

185 y human neutrophils and a corresponding high death rate of mice after injection of these cells.

186 cytosis by human neutrophils, and a very low death rate of mice infected with AP53/covR(+)S(+).

187 The incidence and death rate of pancreatic ductal adenocarcinoma (PDAC) ha

188 The 5-year cumulative melanoma-related death rate of patients with ultrathin melanomas was high

189 The age-standardised death rate of those with a potentially surgical conditio

190 MR study corresponded to low annual MACE and death rates of 0.8% and 0.3%, respectively.

191 940-0.962), with a ratio of trends in annual death rates of 0.981 (95% CI, 0.968-0.993).

192 rtesunate group (n = 1084), corresponding to death rates of 3.9% and 2.9%, respectively.

193 , 64.3%, and 73.9%, respectively, and 90-day death rates of 5.9%, 6.5%, and 6.7% respectively.

194 d produced lower values for the division and death rates of bacteria: these improved the goodness-of-

195 ds to an estimate for the ratio of birth and death rates of cancer cells during the early stages of c

196 have disproportionately higher incidence and death rates of colorectal cancer among all ethnic groups

197 of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirt

198 wer questions about changes in the birth and death rates of lineages in a phylogenetic tree.

199 hly variable, depending mostly on growth and death rates of the individual CLL cell clone.

200 oided if everyone had experienced the lowest death rates of the most educated whites.

201 redraw their original graphs of age-specific death rates of tuberculosis organized either by year of

202 For the incidence (hospitalisation or death) rates of specific diseases, RRs were as follows:

203 facilitating earlier transplant and reducing death rates on the waitlist.

204 a was correlated with change in age-specific death rates only among upper-middle income countries, an

205 crashes have examined only population-based death rates or have been restricted to hospitalized pati

206 olutionary dynamics by cytotoxic (increasing death rate) or cytostatic (decreasing birth rate) therap

207 Crude death rates over a mean follow-up of 1.5 years (SD 1.1)

208 = 0.94; 95% CI: 0.90, 0.97), similar cancer death rates overall (RR = 1.00; 95% CI: 0.93, 1.07), but

209 significantly higher cardiac event rate and death rate (p < 0.001 and p = 0.002, respectively).

210 g and baseline characteristics revealed that death rate (P = .02) and survival duration (P = .01) wer

211 evalent cases showed significantly different death rates (p=0.021), with an overall average mortality

212 h SJS/TEN is rare and associated with a high death rate, particularly in those with jaundice; however

213 Between 1969 and 2013, the age-standardized death rate per 100,000 decreased from 1278.8 to 729.8 fo

214 (ED100000) and age standardized lung cancer death rate per 100,000 people (ASDR100000) in 2004 were

215 loodstream infections (BSIs) and their crude death rate per 1000 occupied bed days (OBDs).

216 ring the mutation rate and the cell survival/death rate per division.

217 9.1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period f

218 We compared adjusted death rates per 5-year intervals, using a piecewise expo

219 The death rate (per 100 patient-years) among those not hospi

220 Death rates ranged from a low of 1.60 (95% CI, 1.07-2.29

221 fidence interval =0.38-0.97), cardiovascular death (rate ratio =0.38, 95% confidence interval =0.20-0

222 =0.48; 95% confidence interval =0.37-0.61), death (rate ratio =0.60; 95% confidence interval =0.38-0

223 , 0.70 [95% CI, 0.56-0.87]) and total HHF/CV death (rate ratio, 0.83 [95% CI, 0.72-0.96]).

224 djusted HCV-associated death rates, compared death rate ratios (DRR) for ten US regions, 50 states, a

225 ted, HCV-associated death rates and compared death rate ratios (DRRs) for 10 US regions, 50 states, a

226 Death rate ratios for women versus men were estimated us

227 A lower than expected prostate cancer death rate reduced ability to detect a between-group dif

228 long-term health benefits including reduced death rates, reduced cardiovascular disease, and reduced

229 nt, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0.9

230 hs in 2020 if 2006 age- and sex-specific CHD death rates remained constant, which would result in app

231 uppression were observed over time; however, death rates remained relatively stable.

232 r if it reduces sudden and unexpected infant death rates remains to be studied.

233 ses a serious health concern, with abuse and death rates rising over recent years.

234 The death rate rose markedly with increasing age, and approx

235 oid leukemia and/or myelodysplastic syndrome death rates (RR = 1.62; 95% CI: 1.05, 2.50); these rates

236 In follow-up, these patients had higher death rates (RR = 3.02; P < .001) and recurrence rates (

237 me per person, maternal education, HIV child death rates, secular shifts, and other factors.

238 57 G.C. Williams predicted that higher adult death rates select for earlier senescence and shorter le

239 Age-adjusted death rates significantly surpassed the US rate for the

240 Age-adjusted death rates significantly surpassed the US rate for the

241 and cardiovascular disease (0.33 [0.20-0.53) death rates still decreased over time.

242 Death rates, survival time, baseline and current CD4 cel

243 Death rates, survival time, baseline and current CD4 cou

244 as associated with a lower treatment-related death rate than a nonpersonalized strategy (median, 1.5%

245 phenotypically unactivated and show a lower death rate than activated T cells, which promotes the su

246 Males had higher overall 10-year death rates than females, both for total deaths (8.9% ve

247 l journals, but that birth rates so exceeded death rates that numbers of biomedical journals continue

248 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase

249 is below both the emergency and the baseline death rate thresholds of sub-Saharan Africa.

250 change in economic insecurity with change in death rates through 2015.

251 We used age-specific death rates to calculate life expectancy at birth and at

252 bined these relative risks with age-specific death rates to get 20-year absolute risks.

253 The cumulative death rates (total 316) were 12% in A, 14% in E, and 10%

254 ons were highly correlated with waiting list death rates, transplantation rates, and MELD score at re

255 Cell death rates trended higher for Neuro2a cells containing

256 his study, we estimate the pooled under-five death rates (U5DR) and assess the effect of drought on c

257 to studying temporal variation in birth and death rates using birth-death models faced difficulties

258 The age-standardised death rates varied substantially from 0.47 (95% UI: 0.34

259 The 30-day stroke rate was 1.1% and the death rate was 0.7%.

260 r patients >70 years old, the sudden cardiac death rate was 1.6 (95% CI, 0.8-3.2) and nonsudden death

261 patients </=70 years old, the sudden cardiac death rate was 1.8 (95% CI, 1.3-2.5) and nonsudden death

262 ascular death rate was 9%, noncardiovascular death rate was 11%, and unknown death rate was 3%.

263 rate was 1.8 (95% CI, 1.3-2.5) and nonsudden death rate was 2.7 (95% CI, 2.1-3.5) events per 100 pati

264 rdiovascular death rate was 11%, and unknown death rate was 3%.

265 rate was 1.6 (95% CI, 0.8-3.2) and nonsudden death rate was 5.4 (95% CI, 3.7-7.8) events per 100 pati

266 Cardiovascular death rate was 9%, noncardiovascular death rate was 11%,

267 Death rate was comparable with the UK population (standa

268 months after cancer treatment decision, and death rate was followed.

269 nsplantation (24% and 24%) were similar, the death rate was higher in the early cohort than in the la

270 e acknowledging that an accurate preventable death rate was lacking.

271 R 33.6%, p = 0.92), whereas in Cohort B, the death rate was lower after TAVR (52.0% vs. 69.6% after s

272 Notably, the incremental change of daily death rate was most prominent during the first week sinc

273 overall decreasing trend in age-standardized death rate was observed for all causes combined, heart d

274 A significantly reduced death rate was observed in the treated cohort as compare

275 cancer was the highest of any cancer and the death rate was second to that of lung cancer.

276 most all within 4 weeks, and a low induction death rate was seen.

277 Overall death rates were 1.16 (control) and 1.49 (IAI); overall

278 All-cause age-standardised death rates were 1.7 times higher in the province with t

279 July); for other/unspecified cardiac causes, death rates were 11.7 (95% CI, 8.6-14.8) per 100000 birt

280 % CI, 0.59-1.30; P = .52), whereas all-cause death rates were 137 vs 444 events, respectively (33.7 a

281 Adjusted death rates were 15.3 per 100,000 population (95% confid

282 In relative terms, adjusted death rates were 2.4 (95% CI: 1.7, 3.0) times higher at

283 8% respectively, and their respective 90-day death rates were 22.8%, 15.1%, and 10.9%.

284 Corresponding 1-year death rates were 4.4%, 9.1%, 20.2%, and 22.4%.

285 The NICU death rates were 7 of 95 neonates (7%) for the 33.5 degr

286 Changes in intentional firearm death rates were analyzed with negative binomial regress

287 patially smoothed county-level heart disease death rates were calculated for 2-year intervals from 19

288 Age-standardised death rates were calculated with mid-year population est

289 In the model, when forager death rates were chronically elevated, an increasingly y

290 At 5 years, all-cause death rates were higher in those with type 2 myocardial

291 Death rates were highest among non-Hispanic (non-H) Amer

292 Death rates were highest among non-Hispanic American Ind

293 The relative death rates were highest among young patients, which was

294 Death rates were independent of maternal CD (60 deaths p

295 In Cohort A, 2-year all-cause death rates were similar (TAVR 35.2% and SAVR 33.6%, p =

296 Death rates were similar between the WPW group versus th

297 Stillbirth and perinatal death rates were similarly not associated with gestation

298 ardial infarction, stroke, or cardiovascular death, rates were 4.6% in PA and 4.5% in the successful

299 dence of an association with firearm-related death rate, with a probability of 0.97 that the death ra

300 UNPD-projected death rates yield a 25.9% reduction of premature mortali